CLIN.L Share News (CLIN)

Clinigen's Idis Starts Managed Access Programme For Horizon's Ravicti

Clinigen's Idis Signs Access Deal For Galen Chemotherapy Drug

Clinigen And Basilea To Run Managed Access Programme For Isavuconazole

Clinigen Inks Deal With Cumberland Pharmaceuticals For Ethyol

Clinigen Buys Rights To Bag Presentation Of Foscavir Treatment

Dividends Calendar - Week Ahead

Clinigen Trading In Line, Buys Totect Drug As First Half Profit Falls

Earnings, Trading Statements Calendar - Week Ahead

Clinigen Group's acquisitions boost first half growth

(ShareCast News) - Clinigen Group says it has had a solid first half performance, driven by acquisitions and organic growth. The AIM-listed company issued a trading update for the six months to 31 December on Tuesday. It said revenue had risen 116% and it had doubled its gross profit from last year

Clinigen First Half Solid With Revenue And Profit Up On Acquisitions

Earnings, Trading Statements Calendar - Week Ahead

BROKER RATINGS SUMMARY: Berenberg Upgrades Meggitt To Buy From Hold

Clinigen Signs Managed Access Programme With Sunesis For Vosaroxin

Clinigen Starts Managed Access Programme For Takeda's Ixazomib

Clinigen Secures Two-Year Renewal On Accord Healthcare Agreement